TY - JOUR
T1 - Acylamino Boronic Acids and Difluoroborane Analogues of Amino Acids
T2 - Potent Inhibitors of Chymotrypsin and Elastase
AU - Kinder, David H.
AU - Katzenellenbogen, John A.
PY - 1985/12
Y1 - 1985/12
N2 - A series of 1-acylamino boronic acids (IA-VA), analogues of the amino acids phenylalanine, phenylglycine, alanine, valine, and isoleucine, were prepared as potential transition-state inhibitors of the serine proteases a-chymotrypsin and elastase, by a boronate homologation reaction. The corresponding difluoroboranes (IB-VB), produced from the boronic acids by treatment with HF, were more easily purified than the boronic acids. Since the difluoroboranes readily hydrolyze in water, they proved to be convenient precursors for the boronic acids. The phenylalanine and phenylglycine analogues I and II were good competitive inhibitors of α-chymotrypsin (Ki = 0.3-8 μM), and the alanine, valine, and isoleucine analogues (III—IV) proved to be good inhibitors of elastase (Ki= 0.1-35 μM). On the basis of their high affinity and the tendency of boronic acids to form borate complexes, these acylamino boronic acids may be behaving as transition-state inhibitors.
AB - A series of 1-acylamino boronic acids (IA-VA), analogues of the amino acids phenylalanine, phenylglycine, alanine, valine, and isoleucine, were prepared as potential transition-state inhibitors of the serine proteases a-chymotrypsin and elastase, by a boronate homologation reaction. The corresponding difluoroboranes (IB-VB), produced from the boronic acids by treatment with HF, were more easily purified than the boronic acids. Since the difluoroboranes readily hydrolyze in water, they proved to be convenient precursors for the boronic acids. The phenylalanine and phenylglycine analogues I and II were good competitive inhibitors of α-chymotrypsin (Ki = 0.3-8 μM), and the alanine, valine, and isoleucine analogues (III—IV) proved to be good inhibitors of elastase (Ki= 0.1-35 μM). On the basis of their high affinity and the tendency of boronic acids to form borate complexes, these acylamino boronic acids may be behaving as transition-state inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=0022356416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022356416&partnerID=8YFLogxK
U2 - 10.1021/jm00150a027
DO - 10.1021/jm00150a027
M3 - Article
C2 - 3851848
AN - SCOPUS:0022356416
SN - 0022-2623
VL - 28
SP - 1917
EP - 1925
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 12
ER -